| Drug NDC: | 64578-0105 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. | |
| Proprietary Name: | Fields Of Flowers |
| Also known as the trade name. It is the name of the product chosen by the labeler. | |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. | |
| Non Proprietary Name: | Homeopathic Liquid |
| Also known as the generic name, this is usually the active ingredient(s) of the product. | |
| Labeler Name: | Energetix Corporation |
| Name of Company corresponding to the labeler code segment of the ProductNDC. | |
| Dosage Form: | Liquid |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. | |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. | |
| Substance Name: | AESCULUS CARNEA FLOWER - 30 [hp_C]/59.1mL AESCULUS HIPPOCASTANUM FLOWER - 30 [hp_C]/59.1mL AGRIMONIA EUPATORIA FLOWER - 30 [hp_C]/59.1mL BROMUS RAMOSUS FLOWER - 30 [hp_C]/59.1mL CALLUNA VULGARIS FLOWERING TOP - 30 [hp_C]/59.1mL CARPINUS BETULUS FLOWERING TOP - 30 [hp_C]/59.1mL CASTANEA SATIVA FLOWER - 30 [hp_C]/59.1mL CENTAURIUM ERYTHRAEA FLOWER - 30 [hp_C]/59.1mL CERATOSTIGMA WILLMOTTIANUM FLOWER - 30 [hp_C]/59.1mL CICHORIUM INTYBUS FLOWER - 30 [hp_C]/59.1mL Load more... CLEMATIS VITALBA FLOWER - 30 [hp_C]/59.1mL FAGUS SYLVATICA FLOWERING TOP - 30 [hp_C]/59.1mL GENTIANELLA AMARELLA FLOWER - 30 [hp_C]/59.1mL HELIANTHEMUM NUMMULARIUM FLOWER - 30 [hp_C]/59.1mL HORSE CHESTNUT - 30 [hp_C]/59.1mL HOTTONIA PALUSTRIS FLOWER - 30 [hp_C]/59.1mL ILEX AQUIFOLIUM FLOWERING TOP - 30 [hp_C]/59.1mL IMPATIENS GLANDULIFERA FLOWER - 30 [hp_C]/59.1mL JUGLANS REGIA FLOWERING TOP - 30 [hp_C]/59.1mL LARIX DECIDUA FLOWERING TOP - 30 [hp_C]/59.1mL LONICERA CAPRIFOLIUM FLOWERING TOP - 30 [hp_C]/59.1mL MALUS DOMESTICA FLOWER - 30 [hp_C]/59.1mL MIMULUS GUTTATUS FLOWERING TOP - 30 [hp_C]/59.1mL OLEA EUROPAEA FLOWER - 30 [hp_C]/59.1mL ORNITHOGALUM UMBELLATUM FLOWERING TOP - 30 [hp_C]/59.1mL PINUS SYLVESTRIS FLOWERING TOP - 30 [hp_C]/59.1mL POPULUS TREMULA FLOWERING TOP - 30 [hp_C]/59.1mL PRUNUS CERASIFERA FLOWER - 30 [hp_C]/59.1mL QUERCUS ROBUR FLOWER - 30 [hp_C]/59.1mL ROSA CANINA FLOWER - 30 [hp_C]/59.1mL SALIX ALBA FLOWERING TOP - 30 [hp_C]/59.1mL SCLERANTHUS ANNUUS FLOWERING TOP - 30 [hp_C]/59.1mL SINAPIS ARVENSIS FLOWERING/FRUITING TOP - 30 [hp_C]/59.1mL ULEX EUROPAEUS FLOWER - 30 [hp_C]/59.1mL ULMUS PROCERA FLOWERING TWIG - 30 [hp_C]/59.1mL VERBENA OFFICINALIS FLOWERING TOP - 30 [hp_C]/59.1mL VITIS VINIFERA FLOWERING TOP - 30 [hp_C]/59.1mL |
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. | |
| Route Details: | ORAL |
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. | |
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. | |
| Marketing Start Date: | 01 Sep, 2017 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. | |
| Marketing End Date: | 25 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. | |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. | |
| Manufacturer Name: | Energetix Corporation |
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. | |
| Original Packager: | Yes |
| Whether or not the drug has been repackaged for distribution. | |
| UNII: | 717DPT98VM KK0Z92II8M 5811MI029U 0W9O574LE8 D9PC510CQV QOI241B01F YHZ719F7M3 B204P54Z1F TP69J995TW HW54500A89 Load more... 7SCP4N87CI 21AF0IHY5U ZKH2SOY1AR 51BRR32WPP 3C18L6RJAZ Q954GT7P3G 5ENR9SAN1W AJU5O1A5ZV 3BA2N709NG 9UMZ642257 1X0T378SXY EF626V855K 192426I5JU 498M34P1VZ CZD6M4PY4B 2HEM73YI9I 5Q01F7TPJJ 0KD7R09EAS ML644HED2V 81MCR2UQ6Q XBP5X7E70R CC4B5WU2XX WWX61E1ZAK 398DBS1PXN J3O020I532 311PNK9CDZ 6TG3V35HTV |
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. | |
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|---|---|---|---|
| 64578-0105-1 | 59.1 mL in 1 BOTTLE, DROPPER (64578-0105-1) | 01 Sep, 2017 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. | ||||
* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.